HSD3B1 and neoplasm: Mechanistically, we identify liver receptor homolog-1 (LRH1/NR5A2) as a key transcriptional regulator of HSD3B1. LRH1 inhibition suppressed HSD3B1 expression, DHEA metabolism, and ER target gene activation, demonstrating its role in sustaining estrogen synthesis and tumor adaptation.